Thinness: Clinical Trials

5 trials for Thinness, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting. 5 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Recruiting 5
Phase 22Recruiting 2

Follow Thinness: new trials by email Literature Review of Thinness trials Research Report on Thinness

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Micronutrient Enhancement for Development and Health in Adolescents - The MEDHA Study
Iron (60 mg)- folic acid (400 ug) [IFA], Multiple micronutrient supplement [MMS], Multiple micronutrient supplement Plus [MMS+] - Neurodevelopment Outcome, Linear Growth
Phase 3RecruitingJohns Hopkins Bloomberg School of Public Health30002026-09-272026-10-09
Visugromab in Cachexia International Trial
Visugromab (CTL-002), Placebo - Cancer-associated Cachexia
Phase 2 / Phase 3RecruitingCatalYm GmbH5182026-04-162026-09-22
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
ponsegromab, placebo - Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Phase 2 / Phase 3RecruitingPfizer9822025-10-032026-10-14
Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea Sequelae
Lactoferrin, Lysozyme, Lactoferrin + Lysozyme - Diarrhea, Wasting
Phase 3RecruitingUniversity of Washington6002023-03-102025-09-11
Management of Shock in Children With SAM or Severe Underweight and Diarrhea
Blood and Dopamine, Blood and adrenaline - Shock Hypovolemic, Shock, Septic
Phase 3RecruitingInternational Centre for Diarrhoeal Disease Research, Bangladesh1352021-08-172025-04-16

Narrower conditions

Cachexia (3)  ·  Anorexia (2)  ·  Neoplasms (2)  ·  Weight Loss (2)  ·  Child Nutrition Disorders (1)  ·  Cholera (1)  ·  Diarrhea (1)  ·  Fatigue (1)  ·  Growth Disorders (1)  ·  Neoplasm Metastasis (1)  ·  Pancreatic Neoplasms (1)  ·  Severe Acute Malnutrition (1)  ·  Shock (1)  ·  Shock, Septic (1)

Broader conditions

Body Weight (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Body Weight Changes (3)  ·  Pathologic Processes (3)  ·  Signs and Symptoms, Digestive (3)  ·  Nutrition Disorders (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)

Interventions

Blood Specimen Collection (1)  ·  Dopamine (1)  ·  Epinephrine (1)  ·  Folic Acid (1)  ·  Iron (1)  ·  Lactoferrin (1)  ·  Muramidase (1)

Sponsors

CatalYm GmbH (1)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (1)  ·  Johns Hopkins Bloomberg School of Public Health (1)  ·  Pfizer (1)  ·  University of Washington (1)

Countries

Bangladesh (2)  ·  Bulgaria (2)  ·  France (2)  ·  Germany (2)  ·  Italy (2)  ·  Poland (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)

Top investigators

Parul Christian, DrPH (1)  ·  Patricia B Pavlinac (1)  ·  Tahmeed Ahmed, PhD (1)

Results publications

PMID 10371570, PMID 1632474, PMID 19593244, PMID 21615299, PMID 21627690, PMID 23496872, PMID 24196006, PMID 24661049, PMID 26323041, PMID 26440279, PMID 27673385, PMID 28144779, PMID 28316439, PMID 28509730, PMID 29318195, PMID 30065491, PMID 31821418, PMID 32032273, PMID 37045565, PMID 39122384, PMID 8194289, PMID 9842034

NIH funding

2025 (1), R01HD103642 (1)